11 research outputs found
Additional file 1: of Reduction of inappropriate medication in older populations by electronic decision support (the PRIMA-eDS study): a qualitative study of practical implementation in primary care
Coding scheme. (PDF 26 kb
Additional file 1: of Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review
Search string search 1 and 2. (DOCX 102 kb
Additional file 4: of Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing
Risk of bias â Clinical trials. (DOCX 71 kb
Additional file 4: of A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol
Data extraction form. (XLSX 41Â kb
Additional file 1: of A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol
Protocol template. (DOCX 51Â kb
Additional file 4: Table S3. of Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
Summary of study findings for the comparison of VKA vs. placebo. Table S4. Summary of study findings for the comparison of VKA vs. antiplatelets. (DOCX 28 kb
Additional file 1: of Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing
Search strings used in the literature database search. (DOC 1066 kb
Additional file 2: of Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing
Additional evidence for recommendations. (DOCX 19 kb
Additional file 2: of Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
Demographic and clinical characteristics per study centre (PDF 109 kb
Additional file 3: of Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
Percentage of the population using substances (ATC level 5) according to polypharmacy status (PDF 41 kb